How The Sanofi (ENXTPA:SAN) Narrative Is Shifting After Valuation Reset And Pipeline Updates [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Sanofi's fair value estimate has been adjusted from €96.10 to €95.53, a trim of about 0.6% that reflects only a modest recalibration rather than a major rethink. This kind of fine tuning mirrors how analysts have been treating large European financials, where small target moves often come down to rebalancing assumptions around execution risks and timing. Read on to see what is driving this shift in the Sanofi story and how you can stay on top of the evolving narrative. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Sanofi. What Wall Street Has Been Saying ?? Bullish Takeaways Several major banks, including RBC Capital, Deutsche Bank, Citi and Barclays, have raised price targets, which signals increased confidence in the company's ability to execute on its plans relative to earlier expectations. RBC Capital highlights cost cutting as a key driver for the "next leg" of the story, suggesting that efficiency
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapsesGlobeNewswire
- Sanofi SA (SNY) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Developments [Yahoo! Finance]Yahoo! Finance
- ???????????(ATV)?????????????????(UTV)??:???????????? [CNET News]CNET News
- Sanofi Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- BNP Paribas Downgrades Sanofi (SNY) with ‘Unlikely Near-Term Rerating' [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 4/23/26 - Form 6-K
- 4/15/26 - Form 6-K
- 4/10/26 - Form SCHEDULE
- SNY's page on the SEC website